Aim shareholders elect all four company director nominees at 2023 annual meeting

Ocala, fla.--(business wire)--aim immunotech inc. (nyse american: aim) (“aim” or the “company”) today announced that shareholders have elected all four of the company's directors, stewart l. appelrouth, nancy k. bryan, thomas k. equels and william m. mitchell, at the company's 2023 annual meeting of stockholders (the “2023 annual meeting”) held today. aim issued the following statement: “we would like to thank our shareholders for their support and engagement throughout this process. our board.
AIM Ratings Summary
AIM Quant Ranking